1180514

Anthony R. Mato, M.D. — FEI 3023220390

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 16, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
New York, NY (United States)

Additional Details

Clinical Investigator (CI)